State workers’ access to weight loss drugs has put House Speaker Tim Moore at odds with State Treasurer Dale Folwell, who ran ...

The company is expected to present critical results from a trial of its CagriSema weight-loss injection in the fourth quarter ...

A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Medicare covers Wegovy as a treatment to reduce the risk of serious cardiovascular events in people who have overweight or obesity. It does not cover Wegovy for weight loss.

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

Medicare covers Wegovy only as a treatment to reduce the risk of heart attacks and strokes in people who have overweight or obesity. It does not cover Wegovy for weight loss. Medicare is currently ...

Originally approved to help with excess weight and obesity, Wegovy and Ozempic, have become synonymous with weight loss fads.

Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is for type 2 diabetes, have become synonymous with weight loss fads.